TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets.

Zhang, Cheng; Xu, Cong; Ma, Chuanshun; Zhang, Qinghua; Bu, Siyuan; Zhang, Dao-Lai; Yu, Liting; Wang, Hongmei

Zhang, Cheng; Xu, Cong; Ma, Chuanshun; Zhang, Qinghua; Bu, Siyuan; Zhang, Dao-Lai; Yu, Liting; Wang, Hongmei.

Afiliação

Zhang C; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Xu C; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Ma C; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Zhang Q; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Bu S; Department of Pharmacology, School of Medicine, Southeast University, Dingjiaqiao 87, Nanjing, China.
Zhang DL; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Yu L; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.
Wang H; Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, China.

Front Mol Biosci ; 9: 915409, 2022.

Article em En | MEDLINE | ID: mdl-35813831

Palavras-chave

bioinformatic; biomarker; ovarian cancer (OV); therapeutic target; transient receptor potential (TRP) channel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Mol Biosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google